Skip to content

Comparison Between Connective Graft and Xenogeneic Matrix, in Patients With Multiple Gingival Recessions

Xenogeneic Collagen Matrix and Connective Tissue Graft Comparison for Multiple Gingival Recessions in Esthetic Areas: A Non-inferiority Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03207984
Enrollment
37
Registered
2017-07-05
Start date
2017-03-08
Completion date
2021-12-01
Last updated
2023-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession, Generalized

Keywords

Gingival Recession, Collagen Matrix, Periodontics

Brief summary

Subepithelial connective tissue graft (SCTG) is considered the gold standard for root coverage treatment. However, it is associated with postoperative morbidity, limited amount of donor tissue, and longer surgical time. Thus, the search for a tissue substitute for SCTG is increasing. Currently, one of the possible autogenous soft tissue substitutes found in the market is the Mucograft® xenogeneic matrix (CM). The results with the use of MC are very promising, both for root coverage as well as for the gain of keratinized tissue. The present study consists of a parallel randomized clinical trial to compare SCTG (control group) and CM (test group) in the treatment of Miller's class I and II gingival recessions, multiple in aesthetic areas (upper central incisors, Lateral and canine).

Detailed description

Obtaining an aesthetic smile is one of the main reasons for the patient's demand for dental treatment, especially when it comes to gingival recession. However, there is a lack of evidence in the literature explaining the most appropriate type of treatment for multiple recessions in aesthetic areas. For unitary gingival recessions, the subepithelial connective tissue graft (SCTG) is considered the gold standard because it presents greater predictability for root coverage. However, it is associated with postoperative morbidity, limited amount of donor tissue, and longer surgical time. Thus, the search for a tissue substitute for SCTG is increasing. Currently, one of the possible autogenous soft tissue substitutes found in the market is the Mucograft® xenogeneic matrix (CM). The results with the use of CM are very promising, both for root coverage as well as for the gain of keratinized mucosa. The present study will consist of a double-blind parallel randomized clinical trial to compare SCTG (control group) and CM (test group) in the treatment of Miller's class I and II gingival recessions, multiple in aesthetic areas (central incisors, Lateral, upper canine). All measurements will be evaluated initially and in the periods of 3, 6, and 12 months after the surgical procedure.

Interventions

PROCEDURERoot coverage surgery

Periodontal plastic surgery aiming the treatment of multiple gingival recessions in aesthetics areas with SCTG and CM

Sponsors

Geistlich Pharma AG
CollaboratorINDUSTRY
University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
15 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Clinical diagnosis of multiple gingival recessions ≥ 2 mm, only in aesthetic areas (upper central and lateral incisive, and canine); * Miller class I and II gingival recession areas * Non-abrasive, erosive, or carious root surfaces * Unrotated, non-extruded, and non-movable teeth * Systemically healthy patients without contraindication to periodontal surgical procedures

Exclusion criteria

* Smokers * Pregnant women and infants * Patients with a history of periodontal disease or recurrent abscess formation * Patients previously submitted to surgical procedures for root coverage * Patients taking anti-convulsant drugs * Antihypertensives, contraceptives or immunosuppressors * Patients with low oral hygiene (plaque and bleeding index over 20%)

Design outcomes

Primary

MeasureTime frameDescription
Gingival recession depth (GRD)one yearDistance in millimeters from ECJ to gingival margin at three points (mesial, center and distal); Distance from cemento-enamel junction to gingival margin = 0 mm

Secondary

MeasureTime frameDescription
Keratinized mucosa widthyearKeratinized mucosa width measured with a periodontal probe in millimeters Ideal if keratinized mucosa width \> 5mm
Dentin hypersensitivityyearDentin hypersensitivity measured by applying an air jet on teeth and patient fills up a visual analogue scale Ideal if scale = 0

Other

MeasureTime frameDescription
Complete root coverageyearAssessed in which the gingival margin was at or above the cementoenamel junction (CEJ)
Soft tissue thickness (STT)yearDetermined at 2mm apical the gingival margin at the central buccal site with anesthetic needle and endodontic stop and digital pachymeter
Probing Depth (PD)yearDistance in millimeters from the gingival margin to the bottom of the gingival sulcus at three points (mesial, center and distal)
Clinical attachment level loss (CAL)yearMeasured in millimeters from the bottom of the periodontal pocket to the cementoenamel junction at three sites per tooth (mesial, center and distal)

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026